S2-E44 - The impact Of the COVID-19 Delta Variant on NAFLD and NASH

Send us Fan MailDonna Cryer joins the Surfers to discuss the different effects that the Delta Variant of COVID-19 is having on different stakeholders within the Fatty Liver community.What impact is the Delta Variant of COVD-19 having on NAFLD and NASH? Let us count the ways in this lively, fast-paced episode with Donna Cryer and the Surfers:16:11 - Global Liver Institute's efforts to drive priority vaccine position for transplant and severely immunocompromised liver patients22:12 - Creating the GLI Patient Insight and Data Center28:26 - Relevance and importance of post-vaccine immunology testing in immunocompromised liver patients33:11 - Perspectives from comparing UK and Israel data and studying the UK experience more generally41:51 - The importance and limits of impact from FDA's full approval of the Pfizer-BioNTech vaccine47:42 - Why Global vaccine equity is so important to the future of the pandemic50:20 - How experience with COVID-19 has improved clinical trial processes and procedures54:30 - How much will Delta and future variants slow the rate of clinical trial progress?